Enhanced Efficacy from Gene Therapy in Pompe Disease Using Coreceptor Blockade

Enzyme replacement therapy (ERT) is the standard-of-care treatment of Pompe disease, a lysosomal storage disorder caused by deficiency of acid α-glucosidase (GAA). One limitation of ERT with recombinant human (rh) GAA is antibody formation against GAA. Similarly, in adeno-associated virus (AAV) vect...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Hum Gene Ther
Autors principals: Han, Sang-oh, Li, Songtao, Brooks, Elizabeth D., Masat, Elisa, Leborgne, Christian, Banugaria, Suhrad, Bird, Andrew, Mingozzi, Federico, Waldmann, Herman, Koeberl, Dwight
Format: Artigo
Idioma:Inglês
Publicat: Mary Ann Liebert, Inc. 2015
Matèries:
Research Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4303018/
https://ncbi.nlm.nih.gov/pubmed/25382056
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/hum.2014.115
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars